The 2020 National Guidelines for the diagnosis and treatment of prostate cancer recommend puncture biopsy when PSA is >10 ng/mL, and that F/T values or other indications should be assessed when PSA ranges from 4-10 ng/mL (gray zone) [20]. This evidence concerns the gene KLK3 and prostate carcinoma.